Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by M Defina
CD34+/Ph+ Cells Are Still Detectable in Chronic Myeloid Leukemia Patients With Sustained and Prolonged Complete Cytogenetic Remission During Treatment With Imatinib Mesylate
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Micro-Rna Response to Imatinib Mesylate in Patients With Chronic Myeloid Leukemia
Haematologica
Hematology
Epstein-Barr Virus-Associated Lymphoproliferative Disease During Imatinib Mesylate Treatment for Chronic Myeloid Leukemia
Haematologica
Hematology
Development of Multiple Myeloma in a Patient With Chronic Myeloid Leukemia After Treatment With Imatinib Mesylate
Oncologist
Cancer Research
Medicine
Oncology
Functional Activity of Cd34-Positive Cells in Chronic Myeloid Leukemia Patients With Different Response to Imatinib Therapy
Experimental Oncology
Cancer Research
Oncology
Alterations in Creatine Kinase, Phosphate and Lipid Values in Patients With Chronic Myeloid Leukemia During Treatment With Imatinib
Haematologica
Hematology
In Vitro Effects of Imatinib on CD34+ Cells of Patients With Chronic Myeloid Leukemia in the Megakaryocytic Crisis Phase
Oncology Letters
Cancer Research
Oncology
Demonstration of Philadelphia Chromosome Negative Abnormal Clones in Patients With Chronic Myelogenous Leukemia During Major Cytogenetic Responses Induced by Imatinib Mesylate
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Long-Term Molecular Responses to Imatinib in Patients With Chronic Myeloid Leukemia: Comparison Between Complete Cytogenetic Responders Treated in Early and in Late Chronic Phase
Haematologica
Hematology
Chromosomal Abnormalities in Philadelphia Chromosome Negative Metaphases Appearing During Imatinib Mesylate Therapy in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Blood
Biochemistry
Immunology
Cell Biology
Hematology
